Crinetics Pharmaceuticals
Crinetics Pharmaceuticals

Crinetics Pharmaceuticals Information

Contact top employees from Crinetics Pharmaceuticals

Summary

Crinetics Pharmaceuticals is a public company that has been in the industry for 18 years. The company currently specializes in the Pharmaceuticals, Biotechnology areas. The position of the Founder & CEO is occupied by Scott R. Struthers. Its headquarters is located at San Diego, California, USA. The number of employees ranges from 25 to 100. The Crinetics Pharmaceuticals annual revenue is estimated at < 1M. Total funding of the company - $181.5M. To connect with Crinetics Pharmaceuticals employee register on SignalHire.

Organization Website

crinetics.com

Social Links

facebooklinkedIntwitter

Phone Number

858-450-6464

Industries

Headquarters Location

6055 Lusk Blvd, San Diego, California, 92121 US

Employees Size

500-1000 employees

Specialties

Pharmaceuticals, Endocrinology, Drug Development

SIC Code

2836

DMA Code

San Diego County

Founded

2008

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
2016Public
Company
25 - 100 10M $178M
2018Public
Company
25 - 100 44M $195M
2009Privately
Held
25 - 100 5.6M $197.7M
2013Public
Company
1.0K - 5.0K 106M $1.5B

Estimated Website Traffic

The chart shows a growth in traffic to the crinetics.com website. In November, traffic increased to 16202, compared to 13789 in the previous month. The highest traffic in 2025 was recorded in November, reaching 16202 visits.

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Crinetics Pharmaceuticals shows a diverse range of experience levels:
14% have been with the company for less than 1 year29% for 1–2 years21% for 3–4 years17% for 5–7 years11% for 8–10 years9% have over 11 years of service at Crinetics Pharmaceuticals
Ex-employees positions
In Company
In New Company
Contact top employees from Crinetics Pharmaceuticals
Stephane Mesaros
Senior Director, Head of PMO
View
Rhorian Moss
Vice President of Sales
View
Yi Ling Hsieh
Director, Drug Product Development CMC
View
Lara Gettys
Director, CDM
View
Arsema Berhe
Sr. Manager, Promotional Review & Asset Management
View
Kim Songco
Director, Clinical Systems and Processes
View
Kim Nguyen
Associate Clinical Trial Management
View
Bastian Ramms
Senior Scientist 1
View
Brent Bowditch
Sr. Manager, Outsourcing and Vendor Governance
View
Sonic Oun
Senior Clinical Trial Manager
View
Megan Turski
Senior Manager, Bioanalysis
View
Madison Holscher
Senior Compensation and Benefits Specialist
View
Tuan Tran
Director of National Accounts West
View
Vincent Li
Regulatory Affairs Manager
View
Brandi Knowles
Senior Contracts Manager, Clinical Research & Development
View
Leighann Timbs
Senior Director, Regulatory Affairs
View
Melissa Fowler
Senior Director
View
Ryan Avenatti
Associate Director, Publications & Medical Communications
View
Neda Emerson
Senior Manager, Financial Reporting & Compliance
View
Janeth Saltos
Senior Business Systems Manager
View
Jason Christenson
Sales Specialist
View
Presheet Patkar
Medical Science Liaison
View
Zara Tian
Associate Director, Drug Substance Development, CMC
View
Marisa
Regional Sales Manager
View
Ziyun Meng
Clinical Data Manager
View
Megan Parks
Director Market Research
View

FAQ

Crinetics Pharmaceuticals operates in the Pharma, Biotech industries. More details can be found on the official website: crinetics.com.
The headquarters of Crinetics Pharmaceuticals are located in San Diego, United States.
The current CEO of Crinetics Pharmaceuticals is Scott R. Struthers
You can contact Crinetics Pharmaceuticals by phone at 858-450-6464.
Crinetics Pharmaceuticals currently employs 500-1000 people.
Crinetics Pharmaceuticals's revenue is approximately < 1M.
Well-known competitors of Crinetics Pharmaceuticals include Keros Therapeutics, Mirum Pharmaceuticals, Inc., Aura Biosciences and Juno Therapeutics, Inc..
BACK TO TOP